Biomimetic nanoparticles co-deliver hirudin and lumbrukinase to ameliorate thrombus and inflammation for atherosclerosis therapy.

Asian J Pharm Sci · 2025 · PMC11795807 · PMID 39917726

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

3.6.4 Safety assay in vivo Changes in weight of mice during the treatment showed that the body weight did not fluctuate significantly in each group and showed a trend of continuous increase (Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.